Brachytherapy and percutaneous stenting in the treatment of cholangiocarcinoma: a prospective randomised study
Language English Country Ireland Media print-electronic
Document type Journal Article, Randomized Controlled Trial
PubMed
17344008
DOI
10.1016/j.ejrad.2007.01.037
PII: S0720-048X(07)00059-9
Knihovny.cz E-resources
- MeSH
- Brachytherapy * methods MeSH
- Radiotherapy Dosage MeSH
- Biliary Tract Surgical Procedures instrumentation MeSH
- Cholangiocarcinoma radiotherapy surgery MeSH
- Adult MeSH
- Kaplan-Meier Estimate MeSH
- Combined Modality Therapy MeSH
- Middle Aged MeSH
- Humans MeSH
- Bile Duct Neoplasms radiotherapy surgery MeSH
- Follow-Up Studies MeSH
- Prospective Studies MeSH
- Iridium Radioisotopes therapeutic use MeSH
- Aged, 80 and over MeSH
- Aged MeSH
- Stents * MeSH
- Treatment Outcome MeSH
- Bile Ducts, Intrahepatic pathology radiation effects surgery MeSH
- Check Tag
- Adult MeSH
- Middle Aged MeSH
- Humans MeSH
- Male MeSH
- Aged, 80 and over MeSH
- Aged MeSH
- Female MeSH
- Publication type
- Journal Article MeSH
- Randomized Controlled Trial MeSH
- Names of Substances
- Iridium Radioisotopes MeSH
PURPOSE: To evaluate the effect of radiation therapy including intraluminal brachytherapy with iridium-192 on survival of patients with malignant biliary strictures (cholangiocarcinoma, histologically improved) treated with metallic stent in a prospective randomised study. METHOD AND MATERIALS: In the prospective randomised study, 21 patients with cholangiocarcinoma were treated with implantation of percutaneous stents followed with intraluminal Ir-192 brachytherapy (mean dose 30 Gy) and external radiotherapy (mean dose 50 Gy) and 21 patients were treated only with stents insertion. We did not find any statistically significant differences in age and tumor localization between these two groups of patients. RESULTS: All the patients died. In the group of patients treated with brachytherapy and with stent implantation, the mean survival time was 387.9 days. In the group of patients treated only with stent insertion the mean survival was 298 days. In effort to eliminate possible effect of external radiotherapy we treated the control group of eight patients with cholangiocarcinoma by stent insertion and brachytherapy only. CONCLUSION: Our results show that combined radiation therapy could extend the survival in the patients with cholangiocarcinoma obstruction.
References provided by Crossref.org